128
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Molecular signatures associated with diuron exposure on rat urothelial mitochondria

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 628-635 | Received 08 Nov 2021, Accepted 30 Mar 2022, Published online: 18 Apr 2022

References

  • Agrawal N, Hossain MS, Skelton AA, Muralidhar K, Kaushik S. 2018. Unraveling the mechanism of L-gulonate-3-dehydrogenase inhibition by ascorbic acid: insights from molecular modeling. Comput Biol Chem. 77:146–153.
  • APVMA. 2011. Review of the mammalian toxicology and metabolism/toxicokinetics of diuron. Armidale: Australian Pesticides and Veterinary Medicines Authority.
  • Ball WB, Neff JK, Gohil VM. 2018. The role of nonbilayer phospholipids in mitochondrial structure and function. FEBS Lett. 592(8):1273–1290.
  • Barros MBL, Pinheiro DR, Borges BN. 2021. Mitochondrial DNA alterations in glioblastoma (GBM). IJMS. 22(11):5855.
  • Braga CP. Adamec J. 2019. Metabolome analysis. In: Shoba Ranganathan MG, Nakai K, Schönbach C, editor. Encyclopedia of bioinformatics and computational biology. New York: Academic Press; p. 463–475.
  • burgos-Aceves MA, Cohen A, Paolella G, Lepretti M, Smith Y, Faggio C, Lionetti L. 2018. Modulation of mitochondrial functions by xenobiotic-induced microRNA: from environmental sentinel organisms to mammals. Sci Total Environ. 645:79–88.
  • Cardoso APF, Catalano SMI, Sanches M, Garcia M, Camargo JLVD, de Oliveira MLSC. 2013. Dose-response of diuron [3-(3,4-dichlorophenyl)-1,1-dimethylurea] in the urothelial mucosa of Wistar rats. Toxicology. 312:1–5.
  • Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, Wishart DS, Xia J. 2018. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 46(W1):W486–W94.
  • Cohen SM, Ohnishi T, Clark NM, He J, Arnold LL. 2007. Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders. Toxicol Pathol. 35(3):337–347.
  • Da Rocha MS, Arnold LL, Dodmane PR, Pennington KL, Qiu F, De Camargo JLV, Cohen SM. 2013. Diuron metabolites and urothelial cytotoxicity: in vivo, in vitro and molecular approaches. Toxicology. 314(2–3):238–246.
  • da Rocha MS, Arnold LL, Oliveira MLSC, Catalano SMI, Cardoso APF. 2014. Diuron-induced rat urinary bladder carcinogenesis: mode of action and human relevance evaluations using the International Programme on Chemical Safety framework. Crit Ver Toxicol. 44:393–406.
  • Da Rocha MS, Arnold LL, Pennington KL, Muirhead D, Dodmane PR, Anwar MM, Battalora M, De Camargo JLV, Cohen SM. 2012. Diuron-induced rat bladder epithelial cytotoxicity. Toxicol Sci. 130(2):281–288.
  • da Rocha MS, Nascimento MG, Cardoso APF, Lima LAD, Zelandi EA, Camargo JLVD, de Oliveira MLS. 2010. Cytotoxicity and regenerative proliferation as the mode of action for Diuron-induced urothelial carcinogenesis in the rat. Toxicol Sci. 113(1):37–44.
  • de Groot M, Lewis D, Modi S. 2007. Molecular modeling and quantitative structure–activity relationship of substrates and inhibitors of drug metabolism enzymes. Comprehensive medicinal chemistry II. 5. Amsterdam: Elsevier.
  • Dreier DA, Mello DF, Meyer JN, Martyniuka CJ. 2019. Linking mitochondrial dysfunction to organismal and population health in the context of environmental pollutants: progress and considerations for mitochondrial adverse outcome pathways. Crit Perspect. 38(8):1625–1634.
  • Esterhuizen K, Van der Westhuizen FH, Louw R. 2017. Metabolomics of mitochondrial disease. Mitochondrion. 35:97–110.
  • Fava RM, Ferragut Cardoso AP, da Rocha MS, Nascimento E Pontes MG, de Camargo JLV, de Oliveira MLCS. 2015. Evaluation of early changes induced by diuron in the rat urinary bladder using different processing methods for scanning electron microscopy. Toxicology. 333:100–106.
  • Ferrucio B, Franchi CAdS, Boldrin NF, de Oliveira MLCS, de Camargo JLV. 2010. Evaluation of Diuron (3-[3,4-dichlorophenyl]-1,1-dimethyl urea) in a two-stage mouse skin carcinogenesis assay. Toxicol Pathol. 38(5):756–764.
  • Frey B, Haupt R, Alms S, Holzmann G, König T, Kern H, Kox W, Rüstow B, Schlame M. 2000. Increase in fragmented phosphatidylcholine in blood plasma by oxidative stress. J Lipid Res. 41(7):1145–1153.
  • Giacomazzi S, Cochet N. 2004. Environmental impact of diuron transformation: a review. Chemosphere. 56(11):1021–1032.
  • HMDB. 2009. 2-Methylhexanoyl-CoA. [accessed 2021 Jan 30]. https://hmdb.ca/metabolites/HMDB0011660.
  • Horecker B. 1976. The biochemistry of sugars. Int Z Vitam Ernahrungsforsch Beih. 15:1–21.
  • Houten SM, Chen J, Belpoggi F, Manservisi F, Sánchez-Guijo A, Wudy SA, Teitelbaum SL. 2016. Changes in the metabolome in response to low-dose exposure to environmental chemicals used in personal care products during different windows of susceptibility. PLoS One. 11(7):e0159919.
  • Huovinen M, Loikkanen J, Naarala J, Vähäkangas K. 2015. Toxicity of diuron in human cancer cells. Toxicol in Vitro. 29(7):1577–1586.
  • Ihlaseh-Catalano SM, Bailey KA, Hester SD, Jones C, Ren H, Cardoso APF, Oliveira MLCS, Wolf DC, de Camargo JLV. 2011. Transcriptional profile of diuron-induced toxicity on the urinary bladder of male Wistar rats to inform mode of action. Toxicol Sci. 122(2):330–338.
  • Ihlaseh-Catalano SM, Bailey KA, Cardoso APF, Ren H, Fry RC, de Camargo JLV, Wolf DC. 2014. Dose and temporal effects on gene expression profiles of urothelial cells from rats exposed to diuron. Toxicology. 325:21–30.
  • Kubiatowski T, Jang T, Lachyankar MB, Salmonsen R, Nabi RR, Quesenberry PJ, Litofsky NS, Ross AH, Recht LD. 2001. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J Neurosurg. 95(3):480–488.
  • Mejia EM, Hatch GM. 2016. Mitochondrial phospholipids: role in mitochondrial function. J Bioenerg Biomembr. 48(2):99–112.
  • Melo CFOR, Delafiori J, de Oliveira DN, Guerreiro TM, Esteves CZ, Lima E. d O, Pando-Robles V, Catharino RR. 2017. Serum metabolic alterations upon Zika infection. Front Microbiol. 8(1954):2373.
  • Meyer JN, Hartman JH, Mello DF. 2018. Mitochondrial toxicity. Toxicol Sci. 162(1):15–23.
  • Nascimento MG, Luiza M, Sartor C, Lima AS, Camargo VD. 2006. Effects of diuron [3-(3,4-dichlorophenyl)-1,1-dimethylurea] on the urinary bladder of male Wistar rats. Toxicology. 224(1–2):66–73.
  • Nishikimi M, Fukuyama R, Minoshima S, Shimizu N, Yagi K. 1994. Cloning and chromosomal mappingo of the human nonfunctional gene for L-gulono-y-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man. J Biol Chem. 269(18):13685–13688.
  • Pascual F. 2021. Reframing the question: does mitochondrial damage set the stage for future inflammation? Environ Health Perspect. 129(6):064001.
  • Pedersen PL, Greenawalt JW, Reynafarje B, Hullihen J, Decker GL, Soper JW. 2019. Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Methods Cell Biol. 78:411–481.
  • Rosivatz E, Woscholski R. 2011. Removal or masking of phosphatidylinositol(4,5)bisphosphate from the outer mitochondrial membrane causes mitochondrial fragmentation. Cell Signal. 23(2):478–486.
  • Roubicek DA, de Souza-Pinto NC. 2017. Mitochondria and mitochondrial DNA as relevant targets for environmental contaminants. Toxicology. 391:100–108.
  • Simões MS, Bracht L, Parizotto AV, Comar JF, Peralta RM, Bracht A. 2017. The metabolic effects of diuron in the rat liver. Environ Toxicol Pharmacol. 54:53–61.
  • Smirnoff N. 2018. Ascorbic acid metabolism and functions: a comparison of plants and mammals. Free Radic Biol Med. 122:116–129.
  • Souza NP, Lima TRR, Pereira LC, Camargo Jlv d. 2020. AOP for urothelial carcinogenesis due to chemical cytotoxicity by mitochondrial impairment. [accessed 2021 Jan 30]. https://aopwiki.org/aops/335.
  • Surowiec I, Noordam R, Bennett K, Beekman M, Slagboom PE, Lundstedt T, van Heemst D. 2019. Metabolomic and lipidomic assessment of the metabolic syndrome in Dutch middle-aged individuals reveals novel biological signatures separating health and disease. Metabolomics. 15(2):23.
  • Szlasa W, Zendran I, Zalesińska A, Tarek M, Kulbacka J. 2020. Lipid composition of the cancer cell membrane. J Bioenerg Biomembr. 52(5):321–342.
  • Tasseva G, Bai HD, Davidescu M, Haromy A, Michelakis E, Vance JE. 2013. Phosphatidylethanolamine deficiency in mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology. J Biol Chem. 288(6):4158–4173.
  • Van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL. 2017. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochem Biophys Acta Biomembr. 1859(9):1558–1572.
  • Vukajlović JM, Drakulić D, Pejić S, Ilić TV, Stefanović A, Petković M. 2020. Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson's disease. Rapid Commun Mass Spectrom. 28(4)34:e8595.
  • Walker DI, Uppal K, Zhang L, Vermeulen R, Smith M, Hu W, Purdue MP, Tang X, Reiss B, Kim S, et al. 2016. High-resolution metabolomics of occupational exposure to trichloroethylene. Int J Epidemiol. 45(5):1517–1527.
  • Wishart DS. 2019. Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev. 99(4):1819–1875.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.